Study results show safety and efficacy profile of once-daily Cipro[R] XR is comparable to conventional Cipro[R]. (01-APR-04) Urologic Nursing

AccessMyLibrary : Search Information that Libraries Trust

AccessMyLibrary Browse U Urologic Nursing Study results show safety and efficacy profile of once-daily Cipro[R] XR is comparable to conventional Cipro[R].(New Products)(Brief Article)

Study results show safety and efficacy profile of once-daily Cipro[R] XR is comparable to conventional Cipro[R].(New Products)(Brief Article)

Publication: Urologic Nursing

Publication Date: 01-APR-04

How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.

Bookmark this article

In a recent study reported by the American Urological Association, researchers announced that study results show that once-daily 1000mg Cipro[R] XR (ciprofloxacin extended-release tablets) are comparable in safety and efficacy to conventional Cipro[R] (ciprofloxacin HCI) in the treatment of complicated urinary tract infections (UTIs) including acute uncomplicated pyelonephritis (AUP)....

Read the full article for free courtesy of your local library.

More Articles from Urologic Nursing

Tips for celebrating National Nurses Week May 6-12.
April 01, 2004

Find companies classified under Pharmaceutical preparations



		What's on AccessMyLibrary? 31,982,826 articles in the following categories: Arts, Business, Consumer News, Culture & Society, Education, Government, Personal Interest, Health, News, Science & Technology


	© 2008 Gale, a part of Cengage Learning	\| All Rights Reserved \| About this Service \| About The Gale Group, a part of Cengage Learning Privacy Policy \| Site Map \| Content Licensing \| Contact Us \| Link to us
		Other Gale sites: Books & Authors \| Goliath \| MovieRetriever.com \| WiseTo Social Issues